Compugroup Net Income From Continuing Ops from 2010 to 2026
| COP Stock | EUR 27.40 0.30 1.11% |
Net Income From Continuing Ops | First Reported 2019-03-31 | Previous Quarter -6 M | Current Value 11 M | Quarterly Volatility 10.5 M |
Check Compugroup Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Compugroup Medical's main balance sheet or income statement drivers, such as Tax Provision of 26 M, Interest Income of 1.2 M or Interest Expense of 40.3 M, as well as many indicators such as . Compugroup financial statements analysis is a perfect complement when working with Compugroup Medical Valuation or Volatility modules.
Compugroup | Net Income From Continuing Ops |
Evaluating Compugroup Medical's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Compugroup Medical SE's fundamental strength.
Latest Compugroup Medical's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Compugroup Medical SE over the last few years. It is Compugroup Medical's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Compugroup Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Compugroup Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 51,685,647 | |
| Geometric Mean | 49,331,043 | |
| Coefficient Of Variation | 33.04 | |
| Mean Deviation | 13,751,384 | |
| Median | 44,470,000 | |
| Standard Deviation | 17,076,564 | |
| Sample Variance | 291.6T | |
| Range | 61.3M | |
| R-Value | 0.12 | |
| Mean Square Error | 306.4T | |
| R-Squared | 0.02 | |
| Significance | 0.64 | |
| Slope | 415,211 | |
| Total Sum of Squares | 4665.7T |
Compugroup Net Income From Continuing Ops History
About Compugroup Medical Financial Statements
Compugroup Medical investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Compugroup Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 31.3 M | 47.4 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Compugroup Stock
Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.